WRBY - Warby Parker Inc.


25.14
-0.750   -2.983%

Share volume: 2,525,198
Last Updated: 04-21-2026
Medical Equipment/Ophthalmic Goods: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$25.89
-0.75
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
35%
Profitability 39%
Dept financing 41%
Liquidity 35%
Performance 30%
Company vs Stock growth
vs
Performance
5 Days
1.13%
1 Month
3.97%
3 Months
-6.02%
6 Months
15.11%
1 Year
74.83%
2 Year
103.07%
Key data
Stock price
$25.14
P/E Ratio 
1,622.16
DAY RANGE
$24.79 - $26.80
EPS 
-$0.04
52 WEEK RANGE
$14.77 - $31.00
52 WEEK CHANGE
$68.50
MARKET CAP 
2.662 B
YIELD 
N/A
SHARES OUTSTANDING 
122.448 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-07-2025
BETA 
1.74
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,338,469
AVERAGE 30 VOLUME 
$2,271,562
Company detail
CEO: Neil Blumenthal
Region: US
Website: warbyparker.com
Employees: 3,030
IPO year: 2021
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Ophthalmic Goods
Sector: Manufacturing

Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses. As of March 17, 2022, it had 160 retail stores in the United States and Canada.

Recent news